Figure 3.
Immunofluorescence staining for pMLC (upper panels), F-actin (mid panels), and E-cadherin (lower panels) of TECs. (a) No treatment; (b) Ang II injection; (c) Ang II + Telmisartan; (d) Ang II + PD123319; (e) Ang II + Blebbistatin. pMLC: phospho-myosin light chain; TECs: tubular epithelial cells; Ang II: angiotensin II.